chevron_leftBack
As of 5 June 2026, ChoA Pharmaceutical Co., LTD. has a market cap of $18.96M USD, ranking #37486 globally and #2382 in South Korea.
It ranks #3355 in the Healthcare sector, and #209 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$18.96MUSD
29.06B KRW
Enterprise Value
$33.01MUSD
50.6B KRW
Revenue (TTM)
$38.69MUSD
59.31B KRW
EBITDA (TTM)
-$2.72MUSD
-4.17B KRW
Net Income (TTM)
-$4.44MUSD
-6.81B KRW
EBITDA Margin
-7%
Profit Margin
-11%
PS Ratio
0.5
PB Ratio
1.3
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.6% | -1.7% | 2.6% | -0.5% | -17% | -13% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
034940
조아제약(주)
ISIN: KR7034940007
Shares Out.:
Shares Outstanding:
30.98M1
Shares Float:
24.916M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
938 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About ChoA Pharmaceutical Co., LTD.
ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral nervous system; gynecologic diseases; antibiotics, antigens, and anthelmintic; and antitumor, as well as other metabolite medicines. The company offers its products in the form of tablets, capsules, granules, syrups, solutions, drinkable ampoules, and sachets. It also provides medicine supply and pharmacy management services. The company exports its products to approximately 20 countries worldwide. The company was founded in 1964 and is headquartered in Seoul, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 317450
|
$539.11M
3K%
826.36B KRW
|
8.4
|
|
KRX: 220100
|
$278.08M
1K%
426.25B KRW
|
-
|
|
KRX: 200130
|
$218.56M
1K%
335.01B KRW
|
-
|
|
KRX: 009290
|
$203.29M
972%
311.61B KRW
|
16.3
|
|
KRX: 194700
|
$167.22M
782%
256.31B KRW
|
7.4
|
|
KRX: 011040
|
$98.78M
421%
151.41B KRW
|
17.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.66B
199K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
156K%
|
-
|
|
SHE: 002001
|
$15.86B
84K%
107.34B CNY
|
16.0
|
|
NSE: CIPLA
|
$11.12B
59K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.0B
58K%
1.05T INR
|
22.7
|
|
SHE: 002653
|
$9.1B
48K%
61.6B CNY
|
80.6
|
chevron_leftBack